A phase I study of immunization with alternating human papillomavirus E7 lipopeptide epitope vaccine and dendritic cells presenting the E7 epitope for the treatment of recurrent or persistent cervical cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Human papillomavirus vaccine (Primary)
- Indications Cervical cancer
- Focus Adverse reactions; Therapeutic Use
- 09 Feb 2009 Biomarkers information updated
- 11 Nov 2005 New trial record.